Study details
Enrolling now
Effect of a Daily Supplement on Plasma PAI-1 Levels
University of California, Los Angeles
NCT IDNCT07469475ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1/2
Ages
18+
Locations
2 sites in CA
About this study
This Phase 1/Phase 2 study is testing Supplement in people with aging.
Based on ClinicalTrials.gov records.
PhasePhase 1/Phase 2
DrugSupplement
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low10%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
dietary supplement, Dermatological Agents (Immunologic Factor Interactions)
Drug routes
oral (Oral Capsule)
Endpoints
Secondary: Change in Blood Level of C-Reactive Protein Between Baseline and 6 Months, Change in Blood Pressure Between Baseline and 6 Months